Bill
SB 974
SB 974 requires Michigan Medicaid to cover OTC and emergency contraception without a prescription starting Jan 1, 2026, expanding access for enrollees but likely raising costs.
Status and basic info
- Bill: SB 974 (adds section 109q to 1939 PA 280, MCL 400.1–400.119b)
- Subject: Human services — medical assistance (Medicaid)
- Sponsor: Sen. Jeff Irwin (primary sponsor listed)
- Introduced: (Senate filing July 2024 / versions circulated subsequently); bill text establishes effective and operative dates
- Current procedural status (per materials provided): placed on second reading
- Key effective date in bill text: coverage to begin January 1, 2026
Purpose and intent
- Require the Michigan Department of Health and Human Services (DHHS) to provide Medicaid coverage for over‑the‑counter (OTC) contraception and emergency contraception without requiring a prescription. The goal is to expand access to contraception for Medicaid enrollees.
Key provisions
- New statutory section (MCL 400.109q): Beginning January 1, 2026, DHHS must provide coverage under the Medical Assistance Program for OTC contraception and emergency contraception without a prescription.
- Definitions:
- “Contraception” — a drug, device, or other product included on the medical assistance preferred drug list and approved by the U.S. Food and Drug Administration (FDA) to prevent pregnancy; explicitly includes hormonal methods administered orally, transdermally, or intravaginally.
- “Emergency contraception” — an FDA‑approved drug to prevent pregnancy after unprotected intercourse or known/suspected contraceptive failure.
- Some introduced versions also specify point‑of‑sale coverage at in‑network pharmacies and state the coverage applies regardless of whether the product is normally a prescription.
Who would be affected
- Primary effect: Michigan Medicaid beneficiaries (enrollees eligible for medical assistance/family planning services).
- Secondary effects: DHHS (program administration), pharmacies and pharmacy benefit processes (point‑of‑sale dispensing), state Medicaid budget and managed care plans.
- No direct changes to private insurance are made by this provision (separate bills may address insurer coverage).
Fiscal and policy impacts
- Nonpartisan committee analyses note uncertainty but indicate there could be a significant fiscal impact on the Medicaid program. Key points:
- Michigan Medicaid already covers many family‑planning services and some OTC products when provided under provider supervision, but existing policy often requires a prescription for OTC products purchased at pharmacies.
- Codifying no‑prescription dispensing for any contraceptive on the Medicaid preferred drug list could increase pharmacy claims and program costs.
- Analyses describe the fiscal impact as potentially significant but uncertain; local units of government are not expected to be fiscally affected.
- Implementation considerations: DHHS would need to update dispensing and pharmacy payment procedures; managed care organizations and pharmacies would need operational guidance.
Related legislation and procedural notes
- Companion bills noted: HB 1013 and HB 1229 (similar provisions in the House).
- The bill amends the Social Welfare Act (Michigan) by adding sec. 109q.
- Legislative analyses and committee reports discuss scope, definitions, and potential cost implications; some earlier versions included point‑of‑sale phrasing and broader language about dispensing at pharmacies.
Bottom line
SB 974 would require Michigan’s Medicaid program to provide OTC contraception and emergency contraception without a prescription beginning January 1, 2026, broadening access for Medicaid enrollees. While consistent with existing family‑planning coverage goals, analysts warn the change could raise Medicaid expenditures; the precise fiscal effect depends on current dispensing practices and utilization after the policy change.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
